Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,431 | 65,624 | 40,030 | 3,803 | N/A |
| Marketable Securities | 5,322 | 1,746 | 23,351 | N/A | N/A |
| TOTAL | $25,179 | $67,977 | $65,246 | $3,823 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,150 | 1,276 | 17 | 13 | N/A |
| Other Non-Current Assets | 116 | 240 | 0 | 2,053 | 0 |
| TOTAL | $1,266 | $1,516 | $17 | $2,066 | $N/A |
| Total Assets | $26,445 | $69,493 | $65,263 | $5,889 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,206 | 17,432 | 3,791 | 3,146 | 0 |
| Accrued Expenses | 4,215 | 8,646 | 4,214 | 1,486 | 0 |
| Other current liabilities | N/A | N/A | N/A | 406 | 0 |
| TOTAL | $18,750 | $30,235 | $8,005 | $18,168 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,221 | 20,174 | 0 | N/A | N/A |
| TOTAL | $11,221 | $20,174 | $N/A | $N/A | $N/A |
| Total Liabilities | $29,971 | $50,409 | $8,005 | $18,168 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,327 | 640 | 514 | N/A | N/A |
| Common Shares | 10 | 41 | 33 | 2 | 0 |
| Retained earnings | -256,346 | -200,979 | -105,644 | -65,230 | N/A |
| Other shareholders' equity | -17 | -29 | -50 | 0 | 0 |
| TOTAL | $-3,526 | $19,084 | $57,258 | $-12,279 | $N/A |
| Total Liabilities And Equity | $26,445 | $69,493 | $65,263 | $5,889 | $0 |